Geron to Present at 2019 Cantor Global Healthcare Conference
September 26 2019 - 4:18PM
Geron Corporation (Nasdaq: GERN) today announced that John A.
Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled
to present a company overview at the 2019 Cantor Global Healthcare
Conference in New York at 9:30 a.m. ET on Friday, October 4, 2019.
A live audio webcast of the presentation will be available on
Geron’s website, www.geron.com/investors/events. If you are unable
to listen to the live presentation, an archived webcast will be
available on the Company’s website for 30 days.
About Geron
Geron is a late-stage clinical biopharmaceutical company focused
on the development and potential commercialization of a
first-in-class telomerase inhibitor, imetelstat, in hematologic
myeloid malignancies. For more information about Geron, visit
www.geron.com.
CONTACT:
Suzanne MessereInvestor and Media
Relationsinvestor@geron.commedia@geron.com
CG Capital877-889-1972
Geron (NASDAQ:GERN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Apr 2023 to Apr 2024